1) sue the FDA, because the 15mg and 30mg are yet marketed and effective,
2) working with the FDA for a quick approval for 5,10,20,40mg (hoping within this year)?
now the real bi9g question is what about the other generic drugs of IPCI pipeline. Could somebody seriously comment this?
the market is not always rational. CTIC are scammers, much better are IMGN and EXEL, but the overreaction for IMGN is a pure hysteria for phase I results, whose benefit percentage normally should be reduced in a phase II-III, for a small target population of 2K-3K women, whose insurance hardly would pay the high cost of such an immunotherapy. Exel is more solid, but I am angry for the inability of SPPI team in advertising their drugs, because some are very promising.
could you , please, tell me why you are so negative on eteplirsen? I am looking at SRPT, but I don't know if it worths buying or not. Thus at the moment I have no any long-sentiment
I scrolled all the list of generics of Qualitest (the Endo generic division). I found the generic Keppra and Effexor, but not Focalin.Thus, if so, Endo does not own a generic Focalin. I suppose that the delay is motivated by the Par buyout. At the moment all Par efforts deal with the Endo agreements. Unfortunately this could last one-two more months.
did people talking of PTX debt take into account the further Zohydro rev. + the potentiality of pediatric label expansion of treximet? Or are they considering the old pipeline? Is it possible that the last disappointing QE could be episodic?
shouldthe PDUFA be scheduled on 5/14/2015? Or not??????
What do you know?